v3.26.1
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) - Derivatives (Parenthetical)
£ in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2026
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2026
GBP (£)
Jun. 30, 2026
USD ($)
Jun. 30, 2026
EUR (€)
Dec. 31, 2025
GBP (£)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
EUR (€)
Schedule of Investments [Line Items]                
Percentage of net assets     149.10% 149.10% 149.10% 145.00% 145.00% 145.00%
Investment, Unaffiliated Issuer                
Schedule of Investments [Line Items]                
US $ Value at Settlement Date       $ 1,938     $ 4,412  
Unrealized Gain/(Loss) $ (40) $ 40            
Percentage of net assets     149.52% [1],[2],[3],[4] 149.52% [1],[2],[3],[4] 149.52% [1],[2],[3],[4] 145.04% [5],[6] 145.04% [5],[6] 145.04% [5],[6]
Investment, Unaffiliated Issuer | Foreign currency forward contracts                
Schedule of Investments [Line Items]                
Percentage of net assets     0.02% [3] 0.02% [3] 0.02% [3] (0.02%) [6] (0.02%) [6] (0.02%) [6]
Open Forward Foreign Currency Contract, Identifier [Axis]: British Pound Sterling (GBP)                
Schedule of Investments [Line Items]                
Amount | £     £ 1,000     £ 2    
US $ Value at Settlement Date       $ 1,350     $ 2,663  
Unrealized Gain/(Loss) (27) 24            
Open Forward Foreign Currency Contract, Identifier [Axis]: Euro (EUR)                
Schedule of Investments [Line Items]                
Amount | €         € 500,000     € 1,500
US $ Value at Settlement Date       $ 588     $ 1,749  
Unrealized Gain/(Loss) $ (13) $ 16            
[1] Non-income producing investments.
[2] The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Unless otherwise indicated, all of the Company’s portfolio company investments are subject to restrictions on sales. As of June 30, 2026, the Company’s portfolio company investments that were subject to restrictions on sales totaled $379.5 million at fair value and represented 149.1% of the Company’s net assets. In addition, unless otherwise indicated, as of June 30, 2026, all investments are pledged as collateral as part of the Company’s revolving credit facility.
[3] Value as a percentage of net assets.
[4] ll investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors (the “Board”).
[5] Non-income producing investments.
[6] Value as a percentage of net assets.